Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 37, Pages E8765-E8774Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1807962115
Keywords
neurodegeneration; development; experimental therapy; animal model; multiomics
Categories
Funding
- Hereditary Disease Foundation Grant
- Maren, Thompson, and McKinney Regenerative Medicine Funds
- McKnight Brain Institute of the University of Florida
- NIH/National Institute of Neurological Disease and Stroke Grant [NS055165]
- High Q Foundation Grant
- European Community RATstream STREP Project Grant [037846]
- Swedish Research Council
- Crafoord Foundation
- Swedish Society for Medical Research
Ask authors/readers for more resources
Huntington disease (HD) is an autosomal dominant neurodegenerative disorder caused by expanded CAG repeats in the huntingtin gene (HIT). Although mutant HTT is expressed during embryonic development and throughout life, clinical HD usually manifests later in adulthood. A number of studies document neurodevelopmental changes associated with mutant HIT, but whether these are reversible under therapy remains unclear. Here, we identify very early behavioral, molecular, and cellular changes in preweaning transgenic HD rats and mice. Reduced ultrasonic vocalization, loss of prepulse inhibition, and increased risk taking are accompanied by disturbances of dopaminergic regulation in vivo, reduced neuronal differentiation capacity in subventricular zone stem/progenitor cells, and impaired neuronal and oligodendrocyte differentiation of mouse embryo-derived neural stem cells in vitro. Interventional treatment of this early phenotype with the histone deacetylase inhibitor (HDACi) LBH589 led to significant improvement in behavioral changes and markers of dopaminergic neurotransmission and complete reversal of aberrant neuronal differentiation in vitro and in vivo. Our data support the notion that neurodevelopmental changes contribute to the prodromal phase of HD and that early, presymptomatic intervention using HDACi may represent a promising novel treatment approach for HD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available